SCHEMBL457792

SCHEMBL457792

Cc1cc(-c2cnc3c(NCCC(F)(F)F)cc(Nc4c(O)cccc4F)nn23)ccc1C(=O)NC1CC1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTK P33981 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL458168 0.91 TTK (0.68) TTK
SCHEMBL457085 0.91 TTK (0.75) TTK
SCHEMBL455493 0.91 TTK (0.70) TTK
SCHEMBL456838 0.91 TTK (0.68) TTK
SCHEMBL458701 0.88 TTK (0.66) TTK
SCHEMBL457791 0.88 TTK (0.66) TTK
SCHEMBL10279712 0.88 TTK (0.75) TTK
SCHEMBL456624 0.88 TTK (0.73) TTK
SCHEMBL457096 0.87 TTK (0.68) TTK
SCHEMBL457935 0.87 TTK (0.69) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014020041-A1 COMBINATIONS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-02-06 WO claimed
EP-2614063-A1 SUBSTITUTED IMIDAZOPYRIDAZINES Bayer Intellectual Property GmbH (DE) 2013-07-17 EP claimed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO claimed